BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 18195066)

  • 1. Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters.
    Kokkotou E; Moss AC; Michos A; Espinoza D; Cloud JW; Mustafa N; O'Brien M; Pothoulakis C; Kelly CP
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1121-6. PubMed ID: 18195066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
    Anton PM; O'Brien M; Kokkotou E; Eisenstein B; Michaelis A; Rothstein D; Paraschos S; Kelly CP; Pothoulakis C
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3975-9. PubMed ID: 15388461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea.
    Berman AL
    J Clin Gastroenterol; 2007; 41(10):932-3. PubMed ID: 18090164
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifaximin in the treatment of recurrent Clostridium difficile infection.
    Mattila E; Arkkila P; Mattila PS; Tarkka E; Tissari P; Anttila VJ
    Aliment Pharmacol Ther; 2013 Jan; 37(1):122-8. PubMed ID: 23095030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.
    Johnson S; Schriever C; Patel U; Patel T; Hecht DW; Gerding DN
    Anaerobe; 2009 Dec; 15(6):290-1. PubMed ID: 19698797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.
    Johnson S; Schriever C; Galang M; Kelly CP; Gerding DN
    Clin Infect Dis; 2007 Mar; 44(6):846-8. PubMed ID: 17304459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
    Nelson RL; Kelsey P; Leeman H; Meardon N; Patel H; Paul K; Rees R; Taylor B; Wood E; Malakun R
    Cochrane Database Syst Rev; 2011 Sep; (9):CD004610. PubMed ID: 21901692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
    Nelson R
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004610. PubMed ID: 17636768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategies for C. difficile associated diarrhea.
    Stepan C; Surawicz CM
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model of Clostridium difficile-associated disease.
    Chen X; Katchar K; Goldsmith JD; Nanthakumar N; Cheknis A; Gerding DN; Kelly CP
    Gastroenterology; 2008 Dec; 135(6):1984-92. PubMed ID: 18848941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of recurrent Clostridium difficile diarrhoea using sequential therapy with vancomycin followed by rifaximin].
    Zelada Rodríguez MA; Rodríguez D; Martí X; Espejo E
    Rev Esp Geriatr Gerontol; 2012; 47(1):42-4. PubMed ID: 22105006
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea.
    Garey KW; Salazar M; Shah D; Rodrigue R; DuPont HL
    Ann Pharmacother; 2008 Jun; 42(6):827-35. PubMed ID: 18430792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series.
    Neff G; Zacharias V; Kaiser TE; Gaddis A; Kemmer N
    Liver Transpl; 2010 Aug; 16(8):960-3. PubMed ID: 20677286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
    Bricker E; Garg R; Nelson R; Loza A; Novak T; Hansen J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004610. PubMed ID: 15674956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Clostridium difficile-associated disease: old therapies and new strategies.
    Aslam S; Hamill RJ; Musher DM
    Lancet Infect Dis; 2005 Sep; 5(9):549-57. PubMed ID: 16122678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea.
    Louie TJ; Peppe J; Watt CK; Johnson D; Mohammed R; Dow G; Weiss K; Simon S; John JF; Garber G; Chasan-Taber S; Davidson DM;
    Clin Infect Dis; 2006 Aug; 43(4):411-20. PubMed ID: 16838228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
    Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M;
    Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.